Yokoyama Yuichiro, Kuramitsu Yasuhiro, Takashima Motonari, Fujimoto Masanori, Iizuka Norio, Terai Shuji, Okita Kiwamu, Sakaida Isao, Oka Masaaki, Raynes Deborah A, Guerriero Vince, Nakamura Kazuyuki
Department of Biochemistry and Functional Proteomics, Yamaguchi University Graduate School of Medicine, Yamaguchi 755-8505, Japan.
Mol Med Rep. 2008 Mar-Apr;1(2):197-201.
Heat shock protein-binding protein 1 (HspBP1) is a co-chaperone that inhibits heat shock 70-kDa protein (Hsp70) activity. In mouse neuroblastomas and lung tumors, the protein levels of HspBP1 and Hsp70 are elevated by a similar amount compared to non-tumor tissues. However, no studies have been reported regarding the levels of HspBP1 in human cancer tissues. Our previous proteomic study demonstrated that the expression of Hsp70 was increased in human hepatitis C virus-related hepatocellular carcinoma (HCV-HCC) tissues. Here, we investigated the expression of HspBP1 in human HCV-HCC. Immunoblotting analysis of HspBP1 and Hsp70 was performed in human HCV-HCC tissues from 20 patients. In 80% of the patients, Hsp70 increased an average of 3.55-fold, and in 50% of the patients, HspBP1 increased an average of 2.02-fold. Comparison and analysis of expression and clinical data revealed a significant difference between moderately-differentiated HCC and non-tumor tissues. In addition, there was a significant difference between the ratio of HspBP1 to Hsp70 levels and tumor size (<3 cm vs. ≥ 3cm) with larger tumors having a lower ratio. This ratio was significantly lower in moderately-differentiated HCC tissues than in non-tumor HCC tissues. In conclusion, HspBP1 was up-regulated in human HCV-HCC, an increase which correlated with the increase of Hsp70 levels. The ratio of HspBP1 to Hsp70 in HCC may provide novel information concerning the characterization of tumors, tumor progression and resistance to treatment.
热休克蛋白结合蛋白1(HspBP1)是一种辅助伴侣蛋白,可抑制热休克70 kDa蛋白(Hsp70)的活性。在小鼠神经母细胞瘤和肺癌中,与非肿瘤组织相比,HspBP1和Hsp70的蛋白水平升高幅度相似。然而,尚未有关于人类癌组织中HspBP1水平的研究报道。我们之前的蛋白质组学研究表明,Hsp70的表达在人类丙型肝炎病毒相关肝细胞癌(HCV-HCC)组织中增加。在此,我们研究了HspBP1在人类HCV-HCC中的表达。对20例患者的人类HCV-HCC组织进行了HspBP1和Hsp70的免疫印迹分析。在80%的患者中,Hsp70平均增加了3.55倍,在50%的患者中,HspBP1平均增加了2.02倍。对表达和临床数据的比较分析显示,中度分化的肝癌与非肿瘤组织之间存在显著差异。此外,HspBP1与Hsp70水平的比值与肿瘤大小(<3 cm对≥3 cm)之间存在显著差异,肿瘤越大,该比值越低。该比值在中度分化的HCC组织中显著低于非肿瘤HCC组织。总之,HspBP1在人类HCV-HCC中上调,这种增加与Hsp70水平的增加相关。HCC中HspBP1与Hsp70的比值可能为肿瘤特征、肿瘤进展和治疗耐药性提供新的信息。